Focus: Levisonics is a public biotechnology company headquartered in Fishers, Indiana, focused on novel platforms for blood coagulation analysis and fluid rheological measurement in hematology. Founded in 2016, the company operates as a specialized biotech with a lean team of approximately 5 active roles.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Levisonics is a high-risk, high-upside platform play best suited for engineers and researchers energized by early-stage innovation, but career security and clinical validation remain unproven.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Levisonics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Levisonics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles